Sinopep-Allsino Biopharmaceutical Co., Ltd. jobs and careers

About Sinopep-Allsino Biopharmaceutical Co., Ltd.

Sinopep is a trusted CDMO specializing in end-to-end CMC development and cGMP manufacturing of peptide and oligonucleotide APIs for NCEs, from early-phase development to commercialization. Since 2009, Sinopep has passed four U.S. FDA inspections and adheres strictly to FDA/ICH guidelines. Our expertise covers process and analytical method development/validation, stability studies, and regulatory support for global filings (IND/NDA). With one of the world's largest and most flexible production capacities, Sinopep supports projects from milligram-scale discovery to 200+ kg commercial batches. By prioritizing early-phase CMC readiness—including Phase 3-ready packages by Phase 2b—we accelerate timelines for fast-track and breakthrough therapies.